Brooks Laboratories
BROOKSNSE

Brooks Laboratories

₹73.55-3.25 (4.23%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
72.96
Today’s high
79.00
52 week low
36.30
52 week high
164.02
Open price
78.90
Previous close
76.80
Live volume
28,956
Lower circuit
69.88
Upper circuit
77.22

Fundamentals

Market Cap
₹217Cr
ROE
20.04%
P/E Ratio(TTM)
8.82
EPS(TTM)
8.35
P/B Ratio
1.77
Dividend Yield
0.00%
Industry P/E
35.05
Book Value
41.64
Debt to Equity
0.07
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹20.65
+23.65%
Profit (Cr)
₹1.52
-72.36%
-100102030
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-14%
3Y CAGR-3%
Profit growthValue
1Y (TTM)+204%
3Y CAGR+25%

About

Brooks Laboratories Limited is a pharmaceutical manufacturing company, producing injectable products like penicillins and cephalosporins for global markets.;
CEO/MD
Dr. Durga Maity
Founded in
2002
NSE symbol
BROOKS

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
52.62%
Retail And Others
36.84%
Mutual Funds
9.90%
Other Domestic Institutions
0.48%
Foreign Institutions
0.17%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹8,391.00
-51.00 (0.60%)
L
    H
    20,956.63111.7524.01
    PfizerPFIZER
    ₹4,460.70
    -46.50 (1.03%)
    L
      H
      20,429.5628.284.86
      ₹1,459.00
      -7.40 (0.50%)
      L
        H
        20,214.1931.225.18
        ₹764.20
        -6.65 (0.86%)
        L
          H
          18,920.5331.83.72
          2026
          29
          May
          Quarterly & Annual Result
          Release date
          6
          Feb
          Quarterly Result
          Release date
          2025
          14
          Nov
          Quarterly Result
          Release date
          13
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks